Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

20.95
-0.6700-3.10%
Post-market: 21.000.0500+0.24%19:55 EDT
Volume:1.39M
Turnover:29.04M
Market Cap:2.56B
PE:13.36
High:21.78
Open:21.71
Low:20.60
Close:21.62
Loading ...

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know

Zacks
·
01 May

Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy?

Zacks
·
30 Apr

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Simply Wall St.
·
30 Apr

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

GlobeNewswire
·
30 Apr

Catalyst Pharmaceuticals Inc. Stock Rallies 2.8%, Outperforms Market

Dow Jones
·
30 Apr

Catalyst Pharmaceuticals Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
26 Apr

Catalyst Pharmaceuticals Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
23 Apr

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

GlobeNewswire
·
22 Apr

BofA Adjusts Price Target on Catalyst Pharmaceuticals to $34 From $33

MT Newswires Live
·
21 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
18 Apr

Citi Remains a Buy on Catalyst Pharma (CPRX)

TIPRANKS
·
17 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
17 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
12 Apr

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

Insider Monkey
·
12 Apr

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip

Simply Wall St.
·
10 Apr

Catalyst Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
09 Apr

BRIEF-Catalyst Pharmaceuticals Announces Health Canada’S Acceptance Of Agamree® New Drug Submission

Reuters
·
08 Apr

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

GlobeNewswire
·
08 Apr

Catalyst Pharmaceuticals Inc. Stock Slides 5.5%, Underperforms Competitors

Dow Jones
·
08 Apr